SYNAGEVA BIOPHARMA CORP
SYNAGEVA BIOPHARMA CORP (GEVA) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 422 transactions totaling $691.2M, demonstrating a bullish sentiment with $466.0M in net insider flow. The most recent transaction on Jun 22, 2015 involved a transaction of 55,479 shares valued at $0.
GEVA Insider Activity Summary
Who Is Buying GEVA Stock?
No significant insider buying has been recorded for GEVA in the recent period.
Who Is Selling GEVA Stock?
No significant insider selling has been recorded for GEVA in the recent period.
Is SYNAGEVA BIOPHARMA CORP Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GEVA is bullish with an Insider Alignment Score of 84/100 and a net flow of $466.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
GEVA Frequently Asked Questions
Understanding GEVA Insider Activity
Insider trading at SYNAGEVA BIOPHARMA CORP (GEVA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading GEVA stock, having executed 422 transactions in the past 90 days. The most active insider is Felix Baker (Executive), who has made 31 transactions totaling $298.5M.
Related Tools
Track SYNAGEVA BIOPHARMA CORP Insider Activity
Get notified when executives and directors at GEVA file new Form 4 transactions